Here are the latest items added to the CTN Dissemination Library for February – March 2024 (this post will be updated as new items come in):  Protocol for Harmonization of Randomized Trials Testing the Addition of Behavioral Therapy to Buprenorphine for Opioid Use Disorder. McHugh RK, et al. Drug and Alcohol Dependence Reports 2024 (in press). (CTN-0030) PrEP for People Who Use Opioids: A NIDA Clinical Trials Network Survey Study in Southern U.S. Cities Where HIV Incidence is High. Hatch M, et al. Drug and Alcohol Dependence 2024;257:111133. (Primary outcomes for CTN-0082) Referral of Patients from Rural Primary Care Clinics to Telemedicine Vendors for Opioid Use Disorder Treatment: A Mixed-Methods…

Here are the latest items added to the CTN Dissemination Library for January – February 2024 (this post will be updated as new items come in): 

This webinar from the CTN Clinical Coordinating Center (CCC) completes a broad overview of the infrastructure of the NIDA CTN, including how Local Nodes interact with the sponsor as well as study sites. A summary of available resources for new nodes and research sites was provided for a variety of Local Node activities. Lastly, best practices were reviewed, as well as ways to avoid common mistakes. Facilitator: Lynn Kunkel, MS, CCRP Presenter: Frankie Kropp, MS, LICDCPresented on February 7, 2024 Watch the recording here | Find more CTN webinars here Posted on February 15, 2024

Here are the latest items added to the CTN Dissemination Library for December 2023 – January 2024 (this post will be updated as new items come in): Webinars Alliances to Disseminate Addiction Prevention and Treatment (ADAPT): A Learning Health System to Improve Evidence-based Practices and Treatment, presented by Matt Aalsma, PhD. (CTN Translation & Implementation SIG webinar, 2023) Human-Centered Implementation Science? Improving the Design and Adaptation of Our Best Interventions and Strategies, presented by Aaron Lyon, PhD. (CTN Translation & Implementation SIG webinar, June 2023) When to Start Caring About Implementability: Pretty Much Now, presented by Geoffrey Curran, PhD. (CTN Translation & Implementation SIG webinar, May 2023) Journal Articles Co-occurring…

Here are the latest items added to the CTN Dissemination Library for October-November 2023 (this post will be updated as new items come in): Prescription Opioid Dose Reductions and Potential Adverse Events: A Multi-Site Observational Cohort Study in Diverse US Health Systems. Metz VE, et al. Journal of General Internal Medicine 2023 (in press). CTN-0084 Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial. Wartko PD, et al. JAMA Internal Medicine 2023:3235701 (in press). CTN-0074 Assessment of Screening Tools to Identify Substance Use Disorders Among Adolescents. Levy S, et al. JAMA Network Open 2023;6(5):e2314422. Research Priorities for Expansion of Opioid Use Disorder Treatment in the…

Here are the latest items added to the CTN Dissemination Library for September-October 2023 (this post will be updated as new items come in): Potential Effect of Antidepressants on Remission from Cocaine Use Disorder — A Nationwide Matched Retrospective Cohort Study. Gao Z, et al. Drug & Alcohol Dependence 2023;251:110958. CTN-0114 Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment. Luo SX, et al. JAMA Psychiatry 2023 (in press). CTN-0027, CTN-0030, CTN-0051 Training Opportunities to Leverage the CTN Network. Crump A. Webinar presented at the NIDA Steering Committee Meeting, September 18, 2023. Implementation of Substance Use Screening in Rural Federally-Qualified Health Center Clinics Identified High Rates of…

This presentation for the NIDA CTN Steering Committee Meeting held on September 18, 2023, featured Aria Crump, ScD, Deputy Director of the NIDA Office of Research, Training, Diversity and Disparities and Director of the NIDA Office of Diversity and Disparities. This 35-minute presentation provides information about different types of funding available through NIDA, focusing on career development and workforce diversity. Dr. Crump reviewed a range of different types of NIDA awards, including R, T, and K awards, HEAL Initiative awards, and unique programs like NIDA’s Loan Repayment Program, which helps early career investigators, especially those from underrepresented backgrounds, repay their student loans. She also demonstrated how to use the NIH…

Here are the latest items added to the CTN Dissemination Library for August-September 2023 (this post will be updated as new items come in): Capturing Drug Use Patterns at a Glance: An n-ary Word Sufficient Statistic for Repeated Univariate Categorical Values. Odom GJ, et al. PLoS One 2023 (in press). CTN-0094 Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use is Legal. Lapham GT, et al. JAMA Network Open 2023;6(8):e2328934. CTN-0077-Ot Integrative Data Analysis of Clinical Trials Network Studies to Examine the Impact of Psychosocial Treatments for Black People Who Use Cocaine: Study Protocol. Haeny AM, et al. Contemporary Clinical…

This post will contain a running list of all items added to the CTN Dissemination Library in July-August 2023. Castillo F, et al. Risks of Returning to Opioid Use at Treatment Entry and Early in Opioid Use Disorder Treatment: Role of Non-Opioid Substances. Drug and Alcohol Dependence 2023 (in press). CTN-0027, CTN-0030, CTN-0051 Parchman ML, et al. Supporting Practice Facilitators in a Learning Health Care System [commentary]. Permanente Journal 2023:23.035 Kidd JD, et al. Sexual Orientation Differences Among Men in a Randomized Clinical Trial of Extended-Release Naltrexone and Bupropion for Methamphetamine Use Disorder. Drug and Alcohol Dependence 2023; 250:110899. (CTN-0068) Trombello JM, et al. Psychometrics of the Concise Health Risk…

New webinar recording available: Research 101 Session 2: FDA Basics & Essential Regulatory Compliance Description:This webinar outlines the basics of FDA oversight and reviews other essential regulatory activities to successfully keep a study in compliance, including ongoing management and reporting requirements. The regulatory portion reviews essential regulatory activities, such as IRB approvals and informed consent requirements. Lastly, there is a discussion of current challenges and best practices when working on regulatory compliance.  Check out the recording here! Posted July 7, 2023